NLRP3 and IL‐1β in macrophages as critical regulators of metabolic diseases
- 4 September 2013
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 15 (s3), 19-25
- https://doi.org/10.1111/dom.12169
Abstract
The activation of the NLRP3 inflammasome leads to the autocleavage and activation of caspase-1. Caspase-1 cleaves several substrates, including the pro-inflammatory cytokine IL-1β. Inflammation, in particular IL-1β, has long been associated with the progression of metabolic disorders, and recent evidence suggests that the NLRP3 inflammasome plays a critical role in this inflammation. This review concentrates on the activation of NLRP3 during the development of metabolic disorders and the effect this activation has on the inflammatory state as well as the metabolic state of the cell.Keywords
This publication has 73 references indexed in Scilit:
- High-Fat Diet Triggers Inflammation-Induced Cleavage of SIRT1 in Adipose Tissue To Promote Metabolic DysfunctionCell Metabolism, 2012
- Mitochondrial Respiratory Capacity Is a Critical Regulator of CD8+ T Cell Memory DevelopmentImmunity, 2012
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1Cell, 2011
- Inflammasomes and autoimmunityTrends in Molecular Medicine, 2011
- Engagement of fatty acids with toll‐like receptor 2 drives interleukin‐1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal–induced gouty arthritisArthritis & Rheumatism, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- The NLR Gene Family: A Standard NomenclatureImmunity, 2008
- Inflammation and metabolic disordersNature, 2006
- Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γNature, 2004
- Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003